drugset / Trial / NCT06289881

Sildenafil 100 mg Tablets Relative to Viagra 100 mg Tablets

NCT06289881

Phase 1 Unknown 36 enrolled Bio-innova Co., Ltd
RandomizedCrossoverOpen-labelBasic science

Summary

The study is to compare the rate and extent of absorption of a generic formulation with that of a reference for mulation when given as equal labeled dose. The study will be randomized, open-label, single dose, two way crossover design with two-period, two-treatment and two-sequence under fasting condition and at least 3 days washout period between the doses.

Timeline

Start
2025-02-04
Primary completion
2025-03-11
Completion
2025-03-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 100 mg

Indications

No indication recorded.